Ferintus 500 mg/10 ml (IV Injection or Infusion)
10 ml vial: ৳ 700.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Ferric carboxymaltose |
| Company | Beximco pharmaceuticals ltd |
| Also available as |
Indications
- Treatment of iron deficiency anemia in adult patients with intolerance to oral iron
- Treatment of iron deficiency anemia in adult patients with unsatisfactory response to oral iron
- Treatment of iron deficiency anemia in adult patients with non-dialysis dependent chronic kidney disease
Description
- Colloidal iron (III) hydroxide in complex with Carboxymaltose
- Carbohydrate polymer that releases iron
Dosage & Administration
- Stepwise approach to determine individual iron need
- Calculation and administration of iron dose(s)
- Post-iron repletion assessments
Interaction
- Formal drug interaction studies not performed
Contraindications
- Hypersensitivity to the active substance
- Hypersensitivity to Ferric Carboxymaltose or any of its excipients
- Known serious hypersensitivity to other parenteral iron products
- Anemia not attributed to iron deficiency
- Evidence of iron overload or disturbances in the utilization of iron
Side Effects
- Nausea
- Headache
- Dizziness
- Hypertension
- Injection site reactions
- Increased alanine aminotransferase
- Hypophosphatemia
- Hypersensitivity
- Dysgeusia
- Tachycardia
- Hypotension
- Flushing
- Dyspnoea
- Dyspepsia
- Abdominal pain
- Constipation
- Diarrhea
- Pruritus
- Urticaria
- Erythema
- Rash
- Myalgia
- Back pain
- Arthralgia
- Muscle spasms
- Pyrexia
- Fatigue
- Chest pain
- Peripheral edema
- Chills
- Increased aspartate aminotransferase
- Increased gamma glutamyl transferase
- Increased blood lactate dehydrogenase
- Increased blood alkaline phosphatase
- Anaphylactoid reactions
- Loss of consciousness
- Anxiety
- Phlebitis
- Syncope
- Presyncope
- Bronchospasm
- Flatulence
- Angioedema
- Pallor
- Face edema
- Rigors
- Malaise
- Influenza-like illness
Pregnancy & Lactation
- Benefit/risk evaluation required before use during pregnancy
- Use during pregnancy only if clearly necessary
- Likely influence on fetal skeletal development
- Limited data on breast-feeding women
Precautions & Warnings
- Serious hypersensitivity reactions reported
- Hypertension
- Transient elevations in systolic blood pressure
- Laboratory test alterations
Use in Special Populations
- Maximum daily injection dose for haemodialysis-dependent chronic kidney disease patients
- Not recommended in children under 14 years
Overdose Effects
- Potential accumulation of iron in storage sites
- Monitoring of iron parameters such as serum ferritin and transferrin saturation recommended
- Consideration of iron chelator use
Therapeutic Class
- Parenteral Iron Preparations
Storage Conditions
- Store in a cool and dry place
- Away from light
- Do not freeze
- Keep out of the reach of children
Related Brands
- Ferisen 100 mg/2 ml (IV Injection or Infusion) - healthcare-pharmaceuticals-ltd
- Xefer 500 mg/10 ml (IV Injection or Infusion) - ziska-pharmaceuticals-ltd
- Ferisen 500 mg/10 ml (IV Injection or Infusion) - healthcare-pharmaceuticals-ltd
- Maltofer 100 mg/2 ml (IV Injection or Infusion) - incepta-pharmaceuticals-ltd
- Maltofer 500 mg/10 ml (IV Injection or Infusion) - incepta-pharmaceuticals-ltd